A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
Authors
Yu Yang (ORCID: https://orcid.org/0000-0002-8988-0790)
Li Zhou (ORCID: https://orcid.org/0000-0003-3874-4833)
A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
Yu Yang, Li Zhou, Yining Zhang, Feihong Luo et al.
Citations
3 citations
Journal
Advances in Therapy
Topics
Hypothalamic control of reproductive hormones
Field-Weighted Citation Impact (FWCI)
1.61
article
A Phase 3, Open-Label, Single-Arm Trial of the Efficacy and Safety of Triptorelin 6-Month Formulation in Chinese Children with Central Precocious Puberty
Yu Yang, Li Zhou, Yining Zhang, Feihong Luo, Xiaoping Luo, Patrick Cabri, Frank Huang, Guimei Li, Chunxiu Gong, Xinran Cheng, Xu Xu, Haiyan Wei, Hui Yao, Yan Zhong, Xiaofeng Shi, Yu Xiao
article en
3 citations
Abstract
No abstract available for this paper.
Publication Tag
Advances in TherapyVol. 41(12)
Institutions
Nanchang University (CN), Ipsen (France) (FR), Capital Medical University (CN), Jilin University (CN), Zhengzhou University (CN), Chengdu Women's and Children's Central Hospital (CN), Zhengzhou Children's Hospital (CN), Shandong Provincial Hospital (CN), First Hospital of Jilin University (CN), Hunan Children's Hospital (CN), Wuhan Children's Hospital (CN), Beijing Children’s Hospital (CN), Jiangxi Provincial Children's Hospital (CN), Wuxi People's Hospital (CN), Children's Hospital of Fudan University (CN), Tongji Hospital (CN), Shandong First Medical University (CN), Huazhong University of Science and Technology (CN)